SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
SEC Accession No. 0001193125-24-088133
Filing Date
2024-04-05
Accepted
2024-04-05 10:53:19
Documents
1
Effectiveness Date
2024-04-05

Document Format Files

Seq Description Document Type Size
1 S-8 POS d815836ds8pos.htm S-8 POS 22641
  Complete submission text file 0001193125-24-088133.txt   23701
Mailing Address 333 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 333 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 650-243-5555
NGM BIOPHARMACEUTICALS INC (Filer) CIK: 0001426332 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 POS | Act: 33 | File No.: 333-254295 | Film No.: 24825193
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)